Hims & Hers Health (HIMS) Stock Price & Analysis
HIMS Stock Chart & Stats
- Day’s Range
- MXN 505.00 - MXN 535.00
- 52-Week Range
- MXN 240.00 - MXN 895.00
- Previous Close
- MXN 558.00
- Volume
- 448
- Average Volume (3M)
- 2,297
- Market Cap
- MXN 121.36B
- Enterprise Value
- MXN 8.74B
- Total Cash (Recent Filing)
- MXN 841.05M
- Total Debt (Recent Filing)
- MXN 1.55B
- Price to Earnings (P/E)
- ―
- Beta
- 0.08
- Next Earnings
- Nov 09, 2026 (Est.)
- EPS Estimate
- 1.07
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue And Subscriber Growth
Rapid revenue growth combined with a nearly three-million subscriber base indicates expanding customer adoption and a larger platform for cross-selling. Continued additions across specialties and geographies can reinforce scale, support recurring demand, and improve the company’s ability to compound revenue over the next several quarters.
Positive Cash Generation
Positive operating and free cash flow provide an important foundation for funding operations and growth without relying entirely on external capital. Generating cash despite a TTM accounting loss suggests the platform retains underlying cash-producing capacity, although conversion should be monitored as the business expands.
AI Efficiency And Engagement Potential
Early AI results point to a scalable improvement in both customer engagement and service efficiency. Higher interaction levels may strengthen the care experience, while reduced nonclinical workload can lower the cost to serve; management expects the investments to pay back within 12–18 months.
Bears Say
Sharp Increase In Leverage
The sharp rise in debt relative to equity materially reduces financial flexibility and increases the consequences of inconsistent profitability. Higher leverage can constrain capital allocation, make growth more dependent on financing capacity, and leave less balance-sheet room to absorb operating setbacks over the next several quarters.
Persistent Gross-Margin Pressure
Margin compression is tied to the strategic shift toward branded weight-loss products and international revenue, which management expects to keep gross margins below historical levels. If this mix persists, the company may need stronger revenue scale or operating efficiencies to protect EBITDA and cash generation.
Regulatory And Legal Uncertainty
The FTC complaint creates an ongoing legal and regulatory overhang that could generate additional costs, management distraction, or changes to operating practices. The uncertainty is particularly relevant to a digitally delivered healthcare model because regulatory outcomes may affect how products and services are marketed or provided.
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
What is Hims & Hers Health’s market cap?
When is Hims & Hers Health’s upcoming earnings report date?
How were Hims & Hers Health’s earnings last quarter?
Is Hims & Hers Health overvalued?
Does Hims & Hers Health pay dividends?
What is Hims & Hers Health’s EPS estimate?
How many shares outstanding does Hims & Hers Health have?
What happened to Hims & Hers Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Hims & Hers Health?
What is the TipRanks Smart Score and how is it calculated?
Hims & Hers Health Stock Smart Score
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Andrew Dudum
- Employees
- 2,442
- Website
- www.hims.com
- Address
- 2269 Chestnut Street, San Francisco, CA, 94123, US
Hims & Hers Health (HIMS) Earnings & Revenues
HIMS Company Deck
HIMS Earnings Call
Earnings Call SentimentPositive
Overall the call conveyed a constructive and growth-oriented outlook: strong revenue and subscriber growth, raised guidance, meaningful international scale from the Eucalyptus acquisition, and promising AI-driven engagement and efficiency gains. These positives are tempered by margin compression from mix shift toward branded weight loss and international sales, a GAAP loss driven by one-time costs, short-term negative cash flow in the quarter, and regulatory/legal uncertainties (FTC action and dependence on FDA rulemaking for peptides). Management highlighted liquidity actions and expects AI investments to pay back within 12–18 months, signaling confidence in the path to improved profitability.
View all MX:HIMS earnings summariesHIMS Net sales Breakdown
- 96.60% Online
- 3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 5 | 11 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 3 | 0 | 9 |
